Primary EBV infection resulting in lymphoproliferative disease in a teenager with Crohn disease.
Gidrewicz
Dominica
D
Department of Pediatrics, Alberta Children's Hospital, Calgary, Alberta, USA.
Lehman
Deborah
D
Rabizadeh
Shervin
S
Majlessipour
Fataneh
F
Dubinsky
Marla
M
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D020031:Epstein-Barr Virus Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069285:Infliximab; D008232:Lymphoproliferative Disorders / Q000150:complications*; D008775:Methylprednisolone / Q000009:adverse effects / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D000069285:Infliximab; D001379:Azathioprine; D008775:Methylprednisolone